Kelly Steven 4
4 · Innovive Pharmaceuticals, Inc. · Filed Jun 30, 2006
Insider Transaction Report
Form 4
Kelly Steven
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2006-06-29+156,301→ 156,301 totalExercise: $3.96From: 2007-06-02Exp: 2016-06-29→ Common Stock (156,301 underlying)
Holdings
- 158,000
Common Stock
Footnotes (1)
- [F1]The options fully vest on June 2, 2007.